The clinical performance is complex and often involves multiple systems. Early identification and normalisation of the diagnosis are essential for improving the prognosis. Diagnosis of the disease requires a combination of clinical performance, imaging inspection, laboratory testing and pathological activation.
The platform can assist in linking a team of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. In recent years, with the development of treatment-oriented, immune-regulatory therapy and precision medicine, many previously difficult-to-treat blood tumour diseases have improved significantly. Treatment requires close monitoring of efficacy and adverse reactions and timely adjustment according to changes in the condition.
Multidisciplinary collaboration (MDT) is particularly important for the comprehensive management of HL accompanying children. 2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3.
Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.